Advances in Nano-Based Drug Delivery and Theranostic Systems
A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Nanoscience".
Deadline for manuscript submissions: 31 October 2025 | Viewed by 19
Special Issue Editors
Interests: nanomedicine; drug/gene delivery; molecular imaging; nano–bio interactions; atherosclerosis; cancer therapy
Interests: nanoparticle; cancer therapy; cancer imaging; immunotherapy; tumor microenvironment
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Recent advancements in nano-engineered materials have revolutionized drug delivery and theranostics in healthcare, enabling precision medicine with improved efficacy and reduced side effects. These nanoscale carriers enhance the bioavailability and stability of drugs, allowing for controlled and targeted release at specific sites. Lipid-based, polymeric, and inorganic nanoparticles facilitate the delivery of a wide range of therapeutics, including chemotherapy agents, RNA-based treatments, and biologics. Hybrid nanoparticles, engineered with dual functionality, enhance disease detection while ensuring precise treatment. Novel innovations integrate therapy with real-time diagnostics where nanoparticles are engineered to be functionalized with imaging agents, such as fluorophores, quantum dots, or magnetic nanoparticles, allowing simultaneous drug delivery and disease monitoring in various disease conditions. Additionally, stimuli-responsive nanoparticles facilitate the systemic release of drugs in response to physiological conditions, such as pH, temperature, or enzymes, thereby optimizing therapeutic outcomes. As nanotechnology advances, personalized medicine and targeted drug delivery systems will continue to evolve, revolutionizing healthcare with more effective treatments and improved patient outcomes. This Special Issue invites the submission of original research or review manuscripts that focus on nanoparticle-based drug delivery and theranostics in diseases, including but not limited to the following areas:
- Response to external or internal stimuli in drug delivery;
- Innovative theranostic nanoparticles for assessing treatment effectiveness;
- Nanocarriers for antibody–drug conjugates;
- Gene delivery systems;
- Nanoparticle-assisted imaging to monitor disease conditions;
- AI in predicting nanoparticle interactions for drug delivery optimization.
Dr. Mukesh Meher
Dr. Yapei Zhang
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- nanoparticles
- smart drug/gene delivery
- multifunctional nanoparticles
- theranostics
- targeted therapy
- molecular imaging
- cancer
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
